Agenus announces virtual annual shareholders meeting

Lexington, mass., may 25, 2022 (globe newswire) -- agenus (nasdaq: agen), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced that its annual shareholders meeting will begin at 3:30 p.m. et on june 8, 2022 and will be conducted in a virtual format only. registration for attendees will start at 3:15 p.m. et.
AGEN Ratings Summary
AGEN Quant Ranking